Affluent Medical SAS AFME Stock Profile

Description: Affluent Medical SA develops minimally invasive medical devices for the treatment of heart and vascular diseases in France. It develops Kardiozis technology for the treatment of abdominal aortic aneurysm; Kalios and Epygon implants to treat mitral insufficiency; and Artus implant, an implantable electro-mechanical artificial sphincter for the treatment of severe urinary incontinence in women and men. The company was founded in 2011 and is based in Aix-en-Provence, France.

Keywords: Medicine Clinical Medicine Implant Vascular Disease Minimally Invasive Procedure Vascular Surgery Urinary Incontinence Aneurysm Aortic Aneurysm Invasive Medical Devices Abdominal Aortic Aneurysm Minimally Invasive Medical Devices Mitral Insufficiency Kardiozis Technology Severe Urinary Incontinence

Home Page: www.affluentmedical.com

320, avenue Archimède
Aix-en-Provence, 13100
France
Phone: 33 4 42 95 12 20

Officers

Name	Title
Mr. Michel Finance	CEO & Chairman
Sebastien Ladet Ph.D.	Chief Exec. Officer
Mr. Jerome Geoffroy	Chief Financial & Admin. Officer
Mr. Olivier Pierron	Deputy Chief Exec. Officer
Prof. Francois Laborde M.D., Ph.D.	Medical Director

Exchange: PA

Country: FR : France

Currency: Euro (€)

Forward PE:	0
Trailing PE:	0
Price-to-Book MRQ:	0.9891
Price-to-Sales TTM:	22.1867
IPO Date:
Fiscal Year End:	December
Full Time Employees:	49

Affluent Medical SAS(AFME)